Snowflake Score | |
---|---|
Valuation | 6/6 |
Future Growth | 5/6 |
Past Performance | 4/6 |
Financial Health | 6/6 |
Dividends | 3/6 |
SELEC Stock Overview
Selçuk Ecza Deposu Ticaret ve Sanayi A.S.
Selçuk Ecza Deposu Ticaret ve Sanayi Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | ₺14.97 |
52 Week High | ₺16.12 |
52 Week Low | ₺7.85 |
Beta | 0.36 |
1 Month Change | 14.36% |
3 Month Change | 24.96% |
1 Year Change | 68.20% |
3 Year Change | 206.76% |
5 Year Change | 265.12% |
Change since IPO | 442.94% |
Recent News & Updates
Shareholder Returns
SELEC | TR Healthcare | TR Market | |
---|---|---|---|
7D | 2.2% | 1.9% | 1.3% |
1Y | 68.2% | -27.5% | 61.2% |
Return vs Industry: SELEC exceeded the TR Healthcare industry which returned -27.5% over the past year.
Return vs Market: SELEC exceeded the TR Market which returned 61.2% over the past year.
Price Volatility
SELEC volatility | |
---|---|
SELEC Average Weekly Movement | 5.6% |
Healthcare Industry Average Movement | 5.3% |
Market Average Movement | 5.9% |
10% most volatile stocks in TR Market | 8.7% |
10% least volatile stocks in TR Market | 4.1% |
Stable Share Price: SELEC is not significantly more volatile than the rest of TR stocks over the past 3 months, typically moving +/- 6% a week.
Volatility Over Time: SELEC's weekly volatility (6%) has been stable over the past year.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
1958 | 6,598 | n/a | https://www.selcukecza.com.tr |
Selçuk Ecza Deposu Ticaret ve Sanayi A.S. operates as a distribution channel between pharmaceutical manufacturers, hospitals, and pharmacies. It also operates a pharmaceutical warehouse. The company was founded in 1958 and is headquartered in Istanbul, Turkey.
Selçuk Ecza Deposu Ticaret ve Sanayi Fundamentals Summary
SELEC fundamental statistics | |
---|---|
Market Cap | ₺9.30b |
Earnings (TTM) | ₺1.19b |
Revenue (TTM) | ₺28.99b |
7.8x
P/E Ratio0.3x
P/S RatioIs SELEC overvalued?
See Fair Value and valuation analysisEarnings & Revenue
SELEC income statement (TTM) | |
---|---|
Revenue | ₺28.99b |
Cost of Revenue | ₺26.33b |
Gross Profit | ₺2.66b |
Other Expenses | ₺1.47b |
Earnings | ₺1.19b |
Last Reported Earnings
Mar 31, 2022
Next Earnings Date
n/a
Earnings per share (EPS) | 1.91 |
Gross Margin | 9.17% |
Net Profit Margin | 4.10% |
Debt/Equity Ratio | 3.2% |
How did SELEC perform over the long term?
See historical performance and comparisonDividends
1.1%
Current Dividend Yield9%
Payout RatioValuation
Is SELEC undervalued compared to its fair value, analyst forecasts and its price relative to the market?
Valuation Score
6/6Valuation Score 6/6
Price-To-Earnings vs Peers
Price-To-Earnings vs Industry
Price-To-Earnings vs Fair Ratio
Below Fair Value
Significantly Below Fair Value
PEG Ratio
Key Valuation Metric
Which metric is best to use when looking at relative valuation for SELEC?
Other financial metrics that can be useful for relative valuation.
What is SELEC's n/a Ratio? | |
---|---|
n/a Ratio | 0x |
n/a | n/a |
Market Cap | ₺9.30b |
Key Statistics | |
---|---|
Enterprise Value/Revenue | 0.3x |
Enterprise Value/EBITDA | 5.8x |
PEG Ratio | 0.3x |
Price to Earnings Ratio vs Peers
How does SELEC's PE Ratio compare to its peers?
SELEC PE Ratio vs Peers |
---|
Company | PE | Estimated Growth | Market Cap |
---|---|---|---|
Peer Average | 28.8x |
Price-To-Earnings vs Peers: SELEC is good value based on its Price-To-Earnings Ratio (7.8x) compared to the peer average (28.8x).
Price to Earnings Ratio vs Industry
How does SELEC's PE Ratio compare vs other companies in the Healthcare Industry?
Price-To-Earnings vs Industry: SELEC is good value based on its Price-To-Earnings Ratio (7.8x) compared to the TR Healthcare industry average (17.9x)
Price to Earnings Ratio vs Fair Ratio
What is SELEC's PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.
Fair Ratio | |
---|---|
Current PE Ratio | 7.8x |
Fair PE Ratio | 15x |
Price-To-Earnings vs Fair Ratio: SELEC is good value based on its Price-To-Earnings Ratio (7.8x) compared to the estimated Fair Price-To-Earnings Ratio (15x).
Share Price vs Fair Value
What is the Fair Price of SELEC when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.
Below Fair Value: SELEC (TRY14.97) is trading below our estimate of fair value (TRY20.66)
Significantly Below Fair Value: SELEC is trading below fair value by more than 20%.
Price to Earnings Growth Ratio
PEG Ratio: SELEC is good value based on its PEG Ratio (0.3x)
Discover undervalued companies
Future Growth
How is Selçuk Ecza Deposu Ticaret ve Sanayi forecast to perform in the next 1 to 3 years based on estimates from 1 analyst?
Future Growth Score
5/6Future Growth Score 5/6
Earnings vs Savings Rate
Earnings vs Market
High Growth Earnings
Revenue vs Market
High Growth Revenue
Future ROE
30.5%
Forecasted annual earnings growth
Earnings and Revenue Growth Forecasts
Analyst Future Growth Forecasts
Earnings vs Savings Rate: SELEC's forecast earnings growth (30.5% per year) is above the savings rate (9%).
Earnings vs Market: SELEC's earnings (30.5% per year) are forecast to grow faster than the TR market (16.1% per year).
High Growth Earnings: SELEC's earnings are expected to grow significantly over the next 3 years.
Revenue vs Market: SELEC's revenue (36.9% per year) is forecast to grow faster than the TR market (13.8% per year).
High Growth Revenue: SELEC's revenue (36.9% per year) is forecast to grow faster than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: Insufficient data to determine if SELEC's Return on Equity is forecast to be high in 3 years time
Discover growth companies
Past Performance
How has Selçuk Ecza Deposu Ticaret ve Sanayi performed over the past 5 years?
Past Performance Score
4/6Past Performance Score 4/6
Quality Earnings
Growing Profit Margin
Earnings Trend
Accelerating Growth
Earnings vs Industry
High ROE
25.3%
Historical annual earnings growth
Earnings and Revenue History
Quality Earnings: SELEC has a high level of non-cash earnings.
Growing Profit Margin: SELEC's current net profit margins (4.1%) are higher than last year (2.9%).
Past Earnings Growth Analysis
Earnings Trend: SELEC's earnings have grown significantly by 25.3% per year over the past 5 years.
Accelerating Growth: SELEC's earnings growth over the past year (90.5%) exceeds its 5-year average (25.3% per year).
Earnings vs Industry: SELEC earnings growth over the past year (90.5%) underperformed the Healthcare industry 169.5%.
Return on Equity
High ROE: SELEC's Return on Equity (24.2%) is considered high.
Discover strong past performing companies
Financial Health
How is Selçuk Ecza Deposu Ticaret ve Sanayi's financial position?
Financial Health Score
6/6Financial Health Score 6/6
Short Term Liabilities
Long Term Liabilities
Debt Level
Reducing Debt
Debt Coverage
Interest Coverage
Financial Position Analysis
Short Term Liabilities: SELEC's short term assets (TRY13.3B) exceed its short term liabilities (TRY9.3B).
Long Term Liabilities: SELEC's short term assets (TRY13.3B) exceed its long term liabilities (TRY213.5M).
Debt to Equity History and Analysis
Debt Level: SELEC has more cash than its total debt.
Reducing Debt: SELEC's debt to equity ratio has reduced from 3.8% to 3.2% over the past 5 years.
Debt Coverage: SELEC's debt is well covered by operating cash flow (48.5%).
Interest Coverage: SELEC earns more interest than it pays, so coverage of interest payments is not a concern.
Balance Sheet
Discover healthy companies
Dividend
What is Selçuk Ecza Deposu Ticaret ve Sanayi current dividend yield, its reliability and sustainability?
Dividend Score
3/6Dividend Score 3/6
Notable Dividend
High Dividend
Stable Dividend
Growing Dividend
Earnings Coverage
Future Dividend Coverage
1.14%
Current Dividend Yield
Dividend Yield vs Market
Notable Dividend: SELEC's dividend (1.14%) is higher than the bottom 25% of dividend payers in the TR market (0.7%).
High Dividend: SELEC's dividend (1.14%) is low compared to the top 25% of dividend payers in the TR market (3.57%).
Stability and Growth of Payments
Stable Dividend: SELEC's dividend payments have been volatile in the past 10 years.
Growing Dividend: SELEC's dividend payments have increased over the past 10 years.
Earnings Payout to Shareholders
Earnings Coverage: With its low payout ratio (8.9%), SELEC's dividend payments are thoroughly covered by earnings.
Cash Payout to Shareholders
Cash Flow Coverage: SELEC is paying a dividend but the company has no free cash flows.
Discover strong dividend paying companies
Management
How experienced are the management team and are they aligned to shareholders interests?
1.4yrs
Average board tenure
CEO
Selçuk Ecza Deposu Ticaret ve Sanayi has no CEO, or we have no data on them.
Board Members
Experienced Board: SELEC's board of directors are not considered experienced ( 1.4 years average tenure), which suggests a new board.
Ownership
Who are the major shareholders and have insiders been buying or selling?
Insider Trading Volume
Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.
Ownership Breakdown
Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.
Top Shareholders
Company Information
Selçuk Ecza Deposu Ticaret ve Sanayi A.S.'s employee growth, exchange listings and data sources
Key Information
- Name: Selçuk Ecza Deposu Ticaret ve Sanayi A.S.
- Ticker: SELEC
- Exchange: IBSE
- Founded: 1958
- Industry: Health Care Distributors
- Sector: Healthcare
- Implied Market Cap: ₺9.296b
- Shares outstanding: 621.00m
- Website: https://www.selcukecza.com.tr
Number of Employees
Location
- Selçuk Ecza Deposu Ticaret ve Sanayi A.S.
- Altunizade Mah.
- Kusbakisi Cad. No:37
- Istanbul
- 34662
- Turkey
Listings
Company Analysis and Financial Data Status
Data | Last Updated (UTC time) |
---|---|
Company Analysis | 2022/06/26 00:00 |
End of Day Share Price | 2022/06/24 00:00 |
Earnings | 2022/03/31 |
Annual Earnings | 2021/12/31 |
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.